Nuzenio

Leerink Partners

Leerink Partners news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Akebia Therapeutics Price Target Announced at $1.00/Share by Leerink Partners - MoomooMoomoo · Sat, 08 Aug 2026 03:40:06 GMTHALOZYME THERAPEUTICS, INC. : LEERINK PARTNERS RAISES TO OUTPERFORM FROM MARKET PERFORM; RAISES TARGET PRICE TO $110 FROM $83 - BitgetBitget · Fri, 07 Aug 2026 14:59:35 GMTAkebia Therapeutics (NASDAQ:AKBA) Downgraded by Leerink Partners to "Market Perform" - MarketBeatMarketBeat · Fri, 07 Aug 2026 13:09:52 GMTHalozyme Therapeutics (NASDAQ:HALO) Upgraded to "Outperform" at Leerink Partners - MarketBeatMarketBeat · Fri, 07 Aug 2026 13:09:51 GMTLeerink Partners Adjusts Price Target on Cencora to $380 From $368 - MoomooMoomoo · Fri, 07 Aug 2026 13:00:35 GMTLatigo: Goldman Sachs & Co. LLC, Jefferies, Leerink Partners and Guggenheim Securities Are Joint Book-Running Managers for the Offering >LTGO - MoomooMoomoo · Fri, 07 Aug 2026 09:44:36 GMTEXELIXIS INC : LEERINK PARTNERS CUTS TO MARKET PERFORM FROM OUTPERFORM - BitgetBitget · Fri, 07 Aug 2026 04:55:12 GMTINSMED INC : LEERINK PARTNERS RAISES TARGET PRICE TO $210.00 FROM $205.00 - BitgetBitget · Fri, 07 Aug 2026 04:52:20 GMT

Timeline

Sat, 08 Aug 2026 03:40:06 GMTAkebia Therapeutics Price Target Announced at $1.00/Share by Leerink Partners - Moomoo
Fri, 07 Aug 2026 14:59:35 GMTHALOZYME THERAPEUTICS, INC. : LEERINK PARTNERS RAISES TO OUTPERFORM FROM MARKET PERFORM; RAISES TARGET PRICE TO $110 FROM $83 - Bitget
Fri, 07 Aug 2026 13:09:52 GMTAkebia Therapeutics (NASDAQ:AKBA) Downgraded by Leerink Partners to "Market Perform" - MarketBeat
Fri, 07 Aug 2026 13:09:51 GMTHalozyme Therapeutics (NASDAQ:HALO) Upgraded to "Outperform" at Leerink Partners - MarketBeat
Fri, 07 Aug 2026 13:00:35 GMTLeerink Partners Adjusts Price Target on Cencora to $380 From $368 - Moomoo
Fri, 07 Aug 2026 09:44:36 GMTLatigo: Goldman Sachs & Co. LLC, Jefferies, Leerink Partners and Guggenheim Securities Are Joint Book-Running Managers for the Offering >LTGO - Moomoo

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Leerink Partners.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.